index	sentence	label
0	The absorption spectrum of the @PROTEIN$ enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-@COMPOUND$ clusters.	1
1	When Vitreoscilla were grown in medium containing 60mM @COMPOUND$ under both normal and limited aeration conditions, the levels of Vitreoscilla @PROTEIN$ (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.	1
2	The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
3	The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
4	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
5	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
6	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
7	@COMPOUND$ supplementation prevents the exercise-induced reduction of serum paraoxonase 1/@PROTEIN$ activities in healthy individuals.	1
8	The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1
9	The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1
10	Treatment of cultured rat cortical neurons with therapeutic concentrations of @COMPOUND$ or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing @PROTEIN$ mRNA, and the activity of BDNF promoter IV.	1
11	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1
12	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1
13	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1
14	Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
15	Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
16	Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1
17	Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0
18	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
19	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
20	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
21	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
22	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
23	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
24	@COMPOUND$ (NAA) is converted into aspartate and acetate by @PROTEIN$.	1
25	N-acetylaspartic acid (NAA) is converted into @COMPOUND$ and acetate by @PROTEIN$.	1
26	N-acetylaspartic acid (NAA) is converted into aspartate and @COMPOUND$ by @PROTEIN$.	1
27	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
28	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
29	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
30	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
31	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
32	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
33	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
34	Selenium and @COMPOUND$ levels were not associated to @PROTEIN$ Abeta42.	0
35	In vitro, the degradation of synthetic Abeta substrate added to @PROTEIN$ was markedly accelerated by low levels (2microM) of exogenous zinc and @COMPOUND$.	1
36	@PROTEIN$ mutation impairs cholinergic modulation of synaptic plasticity and suppresses @COMPOUND$ currents in hippocampus slices.	1
37	Similarly, mutant @PROTEIN$ impairs the ability of the cholinesterase inhibitor @COMPOUND$ to enhance LTP.	1
38	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
39	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
40	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
41	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
42	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
43	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
44	@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1
45	Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher @PROTEIN$ @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
46	Several studies have shown that @PROTEIN$ 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
47	@COMPOUND$-induced depressive-like behavior is mediated by @PROTEIN$ activation in mice.	1
48	We report that peripheral administration of @COMPOUND$ (LPS) activates @PROTEIN$ and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	1
49	Administration of L-@COMPOUND$, a metabolite of tryptophan that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
50	Administration of L-kynurenine, a metabolite of @COMPOUND$ that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
51	@COMPOUND$ enemas upregulate @PROTEIN$ genes expression but decrease adherent mucus thickness in mice colon.	1
52	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1
53	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1
54	@COMPOUND$ especially induced a 6-fold increase in @PROTEIN$ gene expression in proximal colon.	1
55	However, @COMPOUND$ enemas did not modify the number of epithelial cells containing the protein @PROTEIN$, and caused a 2-fold decrease in the thickness of adherent mucus layer.	0
56	However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1
57	Short-term withdrawal of @COMPOUND$ induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial @PROTEIN$.	1
58	It has been shown that the removal efficiency of @PROTEIN$ increased with the increasing applied current density and increasing PAC and @COMPOUND$ (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.	1
59	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
60	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
61	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
62	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
63	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
64	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
65	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
66	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
67	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
68	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
69	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
70	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
71	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
72	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
73	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
74	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
75	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
76	The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
77	The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
78	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
79	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
80	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
81	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
82	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
83	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
84	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
85	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
86	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
87	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
88	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
89	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
90	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
91	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
92	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
93	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
94	@PROTEIN$ did not show any effect in long photoperiod but decreased proliferation by stimulating @COMPOUND$ in short photoperiod.	1
95	To compare the changes in body composition and in @PROTEIN$ levels in postmenopausal women receiving hormone therapy (HT) or @COMPOUND$.	1
96	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
97	Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1
98	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
99	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
100	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
101	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
102	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
103	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
104	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
105	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
106	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
107	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
108	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
109	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
110	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
111	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/Bax ratio and reduction of @PROTEIN$ IV activity.	0
112	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/@PROTEIN$ ratio and reduction of COX IV activity.	0
113	Our results showed that @PROTEIN$ abolished the effect of the oxidant, protecting spermatozoa against reactive @COMPOUND$ species, and improving both sperm motility and chromatin status during incubation.	1
114	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0
115	SMC cultured on P(100/0) films modified by covalently attached @PROTEIN$ or fibrin layers proliferated at a rate comparable to that observed on control tissue culture @COMPOUND$.	0
116	However, prewetting P(70/30) with a @COMPOUND$ buffer prior to aminolysis significantly improved cell numbers following immobilization of @PROTEIN$.	0
117	Our data suggest HumDN1 genotypes are related to total @COMPOUND$ levels in Han Chinese MI patients, but @PROTEIN$ gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	0
118	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (@PROTEIN$) and estrogen receptor-beta (ER-beta).	0
119	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and @PROTEIN$ (ER-beta).	0
120	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), @PROTEIN$ (LHR) and estrogen receptor-beta (ER-beta).	0
121	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (@PROTEIN$).	0
122	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (@PROTEIN$), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	0
123	Results showed that a moderate dose of @PROTEIN$ (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	1
124	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
125	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
126	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0
127	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
128	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
129	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
130	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
131	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
132	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
133	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
134	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
135	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
136	In women, @PROTEIN$ levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and @COMPOUND$ level.	0
137	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
138	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
139	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
140	@PROTEIN$ modulates osteoblast behavior on @COMPOUND$.	1
141	We monitored bcr-@PROTEIN$ transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
142	We monitored @PROTEIN$-abl transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
143	The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1
144	Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0
145	Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1
146	Nicotine, @COMPOUND$, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
147	Nicotine, muscarine, and @COMPOUND$ induced the phosphorylation of @PROTEIN$ and 2.	1
148	@COMPOUND$, muscarine, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
149	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
150	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
151	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
152	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
153	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
154	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
155	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
156	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
157	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
158	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
159	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
160	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, @COMPOUND$ (HA), @PROTEIN$, and decorin in the lamina propria of the scarred vocal folds.	0
161	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, @PROTEIN$, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
162	Histologic examination investigated deposition of extracellular matrix (@PROTEIN$) including collagen, elastin, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
163	Of the compounds synthesized, @COMPOUND$, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-@PROTEIN$ with an IC(50) value of 2.81+/-1.26 microM, which is ca.	1
164	We hypothesise that @COMPOUND$ acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in @PROTEIN$ mutations with mild phenotypes.	0
165	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
166	Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1
167	The present study was undertaken to evaluate the potential role of @PROTEIN$ receptors in the antidepressant-like effect and antinociceptive effect of @COMPOUND$.	0
168	These findings show that @PROTEIN$ receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of @COMPOUND$ in the models investigated.	1
169	In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1
170	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
171	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
172	Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0
173	Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0
174	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
175	ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
176	@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
177	High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1
178	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
179	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
180	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
181	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
182	The expressions of @PROTEIN$ mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by @COMPOUND$ treatment.	1
183	In conclusion, @COMPOUND$ may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of @PROTEIN$ in the local kidney and the urinary excretion of MCP-1.	1
184	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and @COMPOUND$.	1
185	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, @COMPOUND$, zinc and copper.	1
186	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0
187	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0
188	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0
189	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0
190	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
191	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
192	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
193	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
194	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
195	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
196	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
197	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
198	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
199	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
200	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
201	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
202	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
203	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
204	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
205	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
206	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
207	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
208	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
209	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
210	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
211	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
212	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
213	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
214	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
215	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
216	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
217	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
218	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1
219	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
220	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
221	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1
222	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
223	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
224	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
225	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
226	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
227	@COMPOUND$ alone evoked effects similar to low N/@PROTEIN$ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.	0
228	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0
229	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1
230	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in quercetin content relative to @COMPOUND$ in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
231	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in @COMPOUND$ relative to kaempferol in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
232	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
233	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
234	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
235	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
236	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
237	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
238	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
239	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
240	Prediction of @PROTEIN$ receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	1
241	Quantitative structure-activity relationship (QSAR) models were developed to predict for @PROTEIN$ binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas using linear free energy relationship (LFER).	1
242	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and prolactin were reduced only after 3-h @PROTEIN$.	0
243	TT-induced increases in @COMPOUND$, @PROTEIN$ and prolactin were reduced only after 3-h REC.	0
244	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and @PROTEIN$ were reduced only after 3-h REC.	0
245	A series of 2-aryl-naphtho(1,2-d) @COMPOUND$ derivatives have been synthesized and evaluated for @PROTEIN$ inhibitory activity.	0
246	A new series of @COMPOUND$ and aurone derivatives have been synthesized and tested for in vitro @PROTEIN$ inhibitory activity by modified Ellman method.	0
247	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
248	Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0
249	@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	1
250	@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	1
251	Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0
252	Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and @COMPOUND$ scavenging activity of antioxidants.	0
253	Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and @COMPOUND$ scavenging activity of antioxidants.	0
254	Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0
255	Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0
256	The hydrolysis reaction of @COMPOUND$ catalyzed by @PROTEIN$ was followed with in situ UV/vis diode array spectrophotometry.	1
257	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite NaY, on a @COMPOUND$ support and as cross-linked aggregates.	0
258	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite @COMPOUND$, on a polyacrylate support and as cross-linked aggregates.	0
259	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0
260	In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1
261	Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
262	Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
263	Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
264	Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
265	Imatinib is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
266	@COMPOUND$ is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
267	@COMPOUND$ is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
268	@COMPOUND$ is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
269	Imatinib is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
270	In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1
271	The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
272	The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
273	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
274	Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1
275	To investigate this relationship, we used actively growing young Sprague-Dawley rats and @COMPOUND$, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of @PROTEIN$.	0
276	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
277	An alpha-numeric code for representing N-linked @COMPOUND$ structures in secreted @PROTEIN$.	1
278	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1
279	Exogenous spermidine, arsenic and @COMPOUND$ modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
280	Exogenous @COMPOUND$, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
281	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and @PROTEIN$ (ADC)).	1
282	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (@PROTEIN$ PR-1a and PR-2 and arginine decarboxylase (ADC)).	1
283	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (@PROTEIN$)).	1
284	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and @PROTEIN$ and arginine decarboxylase (ADC)).	1
285	Genetic variation in @PROTEIN$ (cholesteryl ester transfer protein) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1
286	Genetic variation in CETP (@PROTEIN$) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1
287	Distribution of the @PROTEIN$ in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, @COMPOUND$ and corticotrophs.	0
288	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
289	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
290	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of @PROTEIN$ and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
291	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-@PROTEIN$ and TGF-beta1, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
292	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and @PROTEIN$, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
293	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and @PROTEIN$, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
294	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
295	The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0
296	The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1
297	In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1
298	Under this condition, a maximum concentration of 300 mg/l of rhG-@PROTEIN$ and the expression yield of 0.6 mg of rhG-CSF/g of @COMPOUND$ were attained.	1
299	Among seven additives tested, @COMPOUND$, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
300	Among seven additives tested, Tween 20, Tween 80 and @COMPOUND$ exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
301	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1
302	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1
303	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
304	The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
305	The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
306	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
307	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
308	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
309	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
310	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
311	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
312	Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1
313	Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0
314	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
315	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
316	Interestingly, @COMPOUND$ inhibited the expression of ICAM and @PROTEIN$, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	1
317	In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1
318	In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1
319	@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1
320	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
321	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
322	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), @PROTEIN$ (COX-2) and the transcription factor NF-kappaB.	1
323	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits @PROTEIN$ (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
324	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (@PROTEIN$), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
325	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (@PROTEIN$) and the transcription factor NF-kappaB.	1
326	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
327	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
328	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
329	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
330	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
331	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
332	@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
333	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
334	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1
335	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
336	However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0
337	Coexpression pattern with @PROTEIN$ provides an indication that @COMPOUND$ could be the modulator of these adaptive responses to involution and dietary P restriction.	1
338	Dietary chia seed (Salvia hispanica L.) rich in @COMPOUND$ improves adiposity and normalises hypertriacylglycerolaemia and @PROTEIN$ resistance in dyslipaemic rats.	1
339	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in @COMPOUND$ and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a sucrose-rich (62.5 %) diet (SRD).	0
340	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in alpha-linolenic acid and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a @COMPOUND$-rich (62.5 %) diet (SRD).	0
341	Pigs fed the high-@COMPOUND$ diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
342	Pigs fed the high-lysine diet moreover had an increased concentration of @COMPOUND$ (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
343	Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of @COMPOUND$ (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
344	@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0
345	@COMPOUND$ attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced @PROTEIN$ activation.	1
346	@COMPOUND$ attenuates @PROTEIN$-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.	1
347	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1
348	Collectively, our findings suggested that the inhibition of JNK and @PROTEIN$ activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
349	Collectively, our findings suggested that the inhibition of @PROTEIN$ and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
350	Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts @PROTEIN$ induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
351	However, the @PROTEIN$ C677T genotype, alone or together with a diet, influenced @COMPOUND$ (P=.03) and phosphatidylcholine (P=.03).	1
352	In addition, the @PROTEIN$ C677T genotype appears to influence the direction and use of @COMPOUND$ moieties in this group of women.	1
353	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
354	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
355	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
356	@COMPOUND$, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
357	Curcumin, demethoxycurcumin and @COMPOUND$ differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
358	Curcumin, @COMPOUND$ and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
359	@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1
360	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
361	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
362	Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the @PROTEIN$ promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
363	Using in vitro binding assays we have demonstrated that @PROTEIN$, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
364	@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1
365	@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1
366	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
367	Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1
368	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
369	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
370	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
371	The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
372	The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
373	The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
374	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and @PROTEIN$, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
375	Circulating @PROTEIN$ was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
376	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of @PROTEIN$.	1
377	Circulating leptin was negatively correlated with mRNA expression of adiponectin, @PROTEIN$ and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
378	This study assessed relationships between @PROTEIN$ levels and @COMPOUND$ uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.	0
379	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of @PROTEIN$ and levels of NMDAR1.	1
380	From the known regulatory mechanisms of Arc expression, HFD reduced @PROTEIN$ (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of NMDAR1.	1
381	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of @PROTEIN$.	0
382	Additionally, we demonstrated that 27-hydroxy@COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
383	Additionally, we demonstrated that @COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
384	@PROTEIN$, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from @COMPOUND$.	1
385	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, @COMPOUND$, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
386	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, @COMPOUND$, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
387	Purified @PROTEIN$ was able to oxidize a variety of substrates including @COMPOUND$+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
388	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, @COMPOUND$, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
389	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, @COMPOUND$, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
390	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, @COMPOUND$, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
391	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, @COMPOUND$, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
392	@COMPOUND$ stabilizes the @PROTEIN$ activity during decolorization of dyes.	1
393	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
394	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
395	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
396	@COMPOUND$ could selectively inhibited @PROTEIN$ expression and PGE2 production.	1
397	Celecoxib could selectively inhibited @PROTEIN$ expression and @COMPOUND$ production.	0
398	@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
399	@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
400	@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
401	@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
402	However, the simultaneous presence of the @PROTEIN$ *1B and CYP3A5 *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
403	However, the simultaneous presence of the CYP3A4 *1B and @PROTEIN$ *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
404	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
405	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1
406	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1
407	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1
408	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1
409	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1
410	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1
411	@COMPOUND$ increased @PROTEIN$ levels after 5 weeks and 6 months of treatment.	1
412	@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1
413	@COMPOUND$ did not affect @PROTEIN$ levels at either time point.	0
414	However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of @COMPOUND$ that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	1
415	However, @COMPOUND$) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	0
416	@COMPOUND$ is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits @PROTEIN$ biomarkers in vitro.	1
417	Lastly, we found that the downstream metabolite of @COMPOUND$, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of @PROTEIN$.	1
418	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
419	We found that @COMPOUND$ induced the activation of JNK, @PROTEIN$, and p38 MAPKs.	1
420	We found that @COMPOUND$ induced the activation of JNK, ERK, and @PROTEIN$.	1
421	We found that @COMPOUND$ induced the activation of @PROTEIN$, ERK, and p38 MAPKs.	1
422	@COMPOUND$-induced JNK activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic @PROTEIN$ and Bcl-xL proteins.	1
423	@COMPOUND$-induced @PROTEIN$ activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic Bcl-2 and Bcl-xL proteins.	1
424	In comparison, @COMPOUND$-induced activation of @PROTEIN$ and p38 in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
425	In comparison, @COMPOUND$-induced activation of ERK and @PROTEIN$ in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
426	Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
427	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
428	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
429	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0
430	Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
431	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
432	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
433	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
434	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
435	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
436	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
437	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
438	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
439	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
440	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased @COMPOUND$ content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	0
441	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased GSH content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	1
442	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of Hpr but decreased GSH content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	1
443	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of Hpr but decreased @COMPOUND$ content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	0
444	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
445	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
446	Plasma @PROTEIN$ 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma @COMPOUND$ concentrations.	0
447	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
448	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
449	injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1
450	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
451	We showed that after treatment of HCT116 cells with a low dose of @COMPOUND$ most of them stopped proliferation as documented by SA-@PROTEIN$ activity and the lack of Ki67 expression.	1
452	Suppressing the activity of @PROTEIN$ in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal @COMPOUND$ uptake.	1
453	Therefore, @PROTEIN$ stands at the crossroad of glucose and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of @COMPOUND$ production, particularly, when mitochondrial biogenesis is reduced.	1
454	Therefore, @PROTEIN$ stands at the crossroad of @COMPOUND$ and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of ATP production, particularly, when mitochondrial biogenesis is reduced.	1
455	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
456	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
457	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
458	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
459	@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1
460	Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1
461	Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1
462	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1
463	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1
464	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
465	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
466	Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
467	Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
468	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
469	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
470	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
471	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
472	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
473	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
474	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
475	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
476	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
477	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
478	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
479	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
480	Activities of microbial extracellular enzymes involved in carbon, @COMPOUND$, and phosphorus cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
481	Activities of microbial extracellular enzymes involved in carbon, nitrogen, and @COMPOUND$ cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
482	Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1
483	Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0
484	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
485	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
486	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
487	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
488	The differences in tissue distribution and protein levels of @PROTEIN$-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of @COMPOUND$ activity in Bombyx anterior silk glands.	1
489	@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1
490	Methylthioadenosine phosphorylase (@PROTEIN$) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to @COMPOUND$.	1
491	Methylation-specific primers were used to analyze methylation of the @PROTEIN$ promoter, using DNA treated with @COMPOUND$.	0
492	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
493	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
494	In experiment 3, administration of E(2) or @COMPOUND$ to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that @PROTEIN$ may be required for some of the anti-depressant-like effects of E(2).	0
495	@COMPOUND$ treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (@PROTEIN$) and AKT was markedly increased in vivo.	1
496	In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1
497	In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1
498	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
499	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
500	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
501	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
502	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
503	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
504	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
505	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0
506	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin @PROTEIN$ (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
507	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (@PROTEIN$), @COMPOUND$ (G), respectively.	0
508	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris @PROTEIN$ (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
509	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (@PROTEIN$-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
510	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), @PROTEIN$ (ALP), @COMPOUND$ (G), respectively.	0
511	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (@PROTEIN$), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
512	The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0
513	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
514	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
515	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
516	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
517	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
518	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
519	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
520	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
521	@PROTEIN$ (GPX1) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1
522	Glutathione peroxidase 1 (@PROTEIN$) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1
523	Whereas their toxicity is due to @PROTEIN$ inhibition, their secondary toxic effects have been related to free @COMPOUND$ radicals.	0
524	@COMPOUND$ diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although testosterone levels remained unaffected.	1
525	Diazinon diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although @COMPOUND$ levels remained unaffected.	0
526	Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1
527	@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0
528	Ran GTPase guanine nucleotide exchange factor @PROTEIN$ is phosphorylated on @COMPOUND$ 11 by cdc2 kinase in vitro.	0
529	Ran GTPase guanine nucleotide exchange factor RCC1 is phosphorylated on @COMPOUND$ 11 by @PROTEIN$ kinase in vitro.	1
530	An RCC1 mutant in which all N-terminal serine and @COMPOUND$ residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
531	An RCC1 mutant in which all N-terminal @COMPOUND$ and threonine residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
532	An RCC1 mutant in which all N-terminal serine and threonine residues were substituted with @COMPOUND$ residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
533	Extracellular lipase @PROTEIN$ prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
534	Extracellular @PROTEIN$ LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
535	The high purity (@COMPOUND$ (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
536	The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
537	The high purity (@COMPOUND$ (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
538	The high purity (S)-ibuprofen (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
539	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
540	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
541	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
542	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
543	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
544	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
545	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
546	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
547	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
548	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
549	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
550	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
551	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
552	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
553	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
554	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of @COMPOUND$ and prednisone compared with mitoxantrone and prednisone.	0
555	BMI and @COMPOUND$ levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with mitoxantrone and prednisone.	0
556	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with @COMPOUND$ and prednisone.	0
557	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and @COMPOUND$ compared with mitoxantrone and prednisone.	0
558	In multivariate analysis, neither BMI, presence of obesity, nor baseline @COMPOUND$ was significantly associated with OS or @PROTEIN$ declines.	0
559	Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
560	Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
561	@PROTEIN$ was increased by @COMPOUND$ in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	1
562	In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0
563	The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
564	The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
565	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, @PROTEIN$ and TSH, seen in both Snell and Ames dwarf mice.	0
566	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced @PROTEIN$ and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice.	0
567	Therefore, @COMPOUND$, which inhibit the production of @PROTEIN$ by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	1
568	@COMPOUND$ levels and hormones (Peptide YY(3-36), @PROTEIN$ (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
569	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, ghrelin, @PROTEIN$) that regulate EI were measured.	0
570	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, @PROTEIN$, insulin) that regulate EI were measured.	0
571	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), @PROTEIN$, ghrelin, insulin) that regulate EI were measured.	0
572	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (@PROTEIN$), leptin, ghrelin, insulin) that regulate EI were measured.	0
573	@COMPOUND$ levels and hormones (@PROTEIN$, glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
574	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
575	With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1
576	With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0
577	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0
578	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0
579	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
580	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
581	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
582	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
583	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
584	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
585	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
586	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
587	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
588	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
589	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1
590	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1
591	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1
592	On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0
593	In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1
594	A 23.5-fold increase in @COMPOUND$ O-deethylation activity suggested that metabolic resistance through elevated levels of @PROTEIN$ dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	1
595	Natural @COMPOUND$ was enzymatically polymerized using soybean @PROTEIN$.	1
596	Vesicle mobilization requires @COMPOUND$+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (@PROTEIN$) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).	1
597	These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0
598	This additive effect was not observed when glioma cells were pre-treated with @COMPOUND$, which was unable to increase @PROTEIN$ expression in tumor.	0
599	Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1
600	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
601	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
602	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
603	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
604	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
605	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
606	Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1
607	Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1
608	Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1
609	Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1
610	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	1
611	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	0
612	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	1
613	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	0
614	The present findings suggest that the efficacy of betaxolol treatment on @COMPOUND$ withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	0
615	The present findings suggest that the efficacy of @COMPOUND$ treatment on cocaine withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	1
616	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
617	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
618	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
619	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
620	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
621	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
622	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
623	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1
624	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1
625	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is @PROTEIN$-dependent and is associated with enhanced insulin secretion.	1
626	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced @PROTEIN$ secretion.	1
627	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of @PROTEIN$ is JAK2-dependent and is associated with enhanced insulin secretion.	1
628	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1
629	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0
630	In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1
631	@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1
632	The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
633	The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
634	Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
635	Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
636	@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
637	@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
638	A combination of @COMPOUND$ and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
639	A combination of niacin and @COMPOUND$ did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
640	We hypothesize that the stimulation of @PROTEIN$ gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by PPARalpha pathway(s).	1
641	We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by @PROTEIN$ pathway(s).	1
642	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1
643	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0
644	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0
645	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1
646	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0
647	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1
648	A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0
649	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	1
650	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	0
651	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	1
652	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	0
653	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	0
654	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	1
655	Inhibition of protein synthesis by @COMPOUND$ reduces @PROTEIN$ expression in normoxic and hypoxic pancreatic cancer cells.	1
656	Western blot analyses of @COMPOUND$-treated cells demonstrated that imexon reduces @PROTEIN$ protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.	1
657	@COMPOUND$ did not similarly affect @PROTEIN$ levels.	0
658	Concurrently, the half-life of existing @PROTEIN$ protein was increased by @COMPOUND$, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	1
659	The inhibition of @PROTEIN$ translation was not specific, rather it was part of a general decrease in protein translation caused by @COMPOUND$.	1
660	For this purpose, human erythrocyte @PROTEIN$ was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP @COMPOUND$ 4B affinity gel and Sephadex G-200 gel filtration chromatography.	0
661	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1
662	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1
663	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1
664	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
665	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
666	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
667	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
668	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
669	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
670	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
671	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
672	@COMPOUND$, a SSRI, is mainly metabolized by cytochrome P450 (@PROTEIN$) 2D6 and 1A2.	1
673	@COMPOUND$, a SSRI, is mainly metabolized by @PROTEIN$ (CYP) 2D6 and 1A2.	1
674	Indoleamine 2,3-dioxygenase (@PROTEIN$) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
675	@PROTEIN$ (IDO) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
676	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
677	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
678	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
679	We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) @COMPOUND$, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (@PROTEIN$).	0
680	@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1
681	@PROTEIN$ inhibitory activity of @COMPOUND$ and synergistic effect with acarbose.	1
682	@PROTEIN$ inhibitory activity of cyanidin-3-galactoside and synergistic effect with @COMPOUND$.	1
683	Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0
684	@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0
685	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
686	Comparison of the PTM's of @PROTEIN$'s isolated from several vertebrate species reveals marked differences in their @COMPOUND$ content.	1
687	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated serine and @COMPOUND$ residues in common with mammalian MBP.	1
688	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated @COMPOUND$ and threonine residues in common with mammalian MBP.	1
689	@COMPOUND$/NaPB administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
690	Riluzole/@COMPOUND$ administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
691	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
692	The planar angle between the carbamoyl phosphate and @COMPOUND$ domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
693	The planar angle between the @COMPOUND$ and aspartate domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
694	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
695	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
696	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
697	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
698	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
699	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
700	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1
701	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0
702	The free radicals produced are thought to be generated during the production of @COMPOUND$, a reaction catalyzed by @PROTEIN$.	1
703	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and @PROTEIN$ activities were observed.	0
704	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and @PROTEIN$ activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
705	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, @PROTEIN$ and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
706	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of tumor necrosis factor-alpha (@PROTEIN$).	1
707	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of @PROTEIN$-alpha (TNF-alpha).	1
708	In the central nervous system, @PROTEIN$ is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and @COMPOUND$ accumulation.	1
709	@COMPOUND$ has been shown to down-regulate the production of @PROTEIN$.	1
710	This study was performed to investigate the effect of combined treatment with @COMPOUND$ and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
711	This study was performed to investigate the effect of combined treatment with niacin and @COMPOUND$ on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
712	In HF group, the serum levels of total @COMPOUND$ (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of @PROTEIN$ (HDL), serum NO were lower than those in CG group.	0
713	These findings indicated that combined treatment with niacin and @COMPOUND$ has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
714	These findings indicated that combined treatment with @COMPOUND$ and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
715	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
716	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
717	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
718	The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
719	The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
720	Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
721	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
722	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0
723	Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0
724	Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0
725	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and insulin secretion.	1
726	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and @PROTEIN$ secretion.	1
727	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and insulin secretion.	1
728	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and @PROTEIN$ secretion.	0
729	Neither @PROTEIN$ expression nor UCP2 overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
730	Neither UCP1 expression nor @PROTEIN$ overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
731	Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, @PROTEIN$ *1502, are at a higher risk for Stevens-Johnson syndrome when using @COMPOUND$, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.	1
732	Oral administration of @COMPOUND$ remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total bilirubin levels.	1
733	Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total @COMPOUND$ levels.	0
734	@COMPOUND$ reduces induction of @PROTEIN$ and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	1
735	We found that while OM24 treatment did not significantly affect UV-induced erythema and @COMPOUND$ dimer formation, OM24 treatment significantly reduced UV-induced @PROTEIN$ expression in keratinocytes.	0
736	Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
737	Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
738	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
739	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
740	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
741	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
742	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
743	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
744	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
745	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
746	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
747	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
748	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
749	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
750	In the present study, we measured plasma @PROTEIN$ levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli @COMPOUND$ per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	0
751	Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1
752	Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0
753	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
754	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
755	Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by @PROTEIN$, which involves limited conformational changes including @COMPOUND$ trans to cis isomerization.	1
756	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low @COMPOUND$ (rT3) levels.	1
757	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (@COMPOUND$) levels.	1
758	Results showed that MENT treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and @COMPOUND$.	1
759	Results showed that @COMPOUND$ treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and DHT.	1
760	The studies with @COMPOUND$ showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	0
761	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of @COMPOUND$ to the 5-AR.	0
762	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into @COMPOUND$ significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	1
763	Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood @COMPOUND$ and glycated @PROTEIN$ levels.	0
764	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
765	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
766	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
767	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
768	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
769	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
770	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
771	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
772	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
773	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
774	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
775	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
776	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
777	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
778	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
779	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
780	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by @COMPOUND$ (MTT), @PROTEIN$-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
781	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-FITC/@COMPOUND$ (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
782	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-@COMPOUND$/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
783	Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the @PROTEIN$ mechanism (sulphur of the @COMPOUND$ residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.	1
784	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
785	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
786	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0
787	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
788	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
789	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
790	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
791	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
792	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
793	The @PROTEIN$ insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent @COMPOUND$ generation: potential implication in hypertension.	1
794	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and Kdap, but downregulated expression of @PROTEIN$.	0
795	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of @PROTEIN$ and Kdap, but downregulated expression of involucrin.	0
796	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and @PROTEIN$, but downregulated expression of involucrin.	0
797	The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to @COMPOUND$ through the oxidation reaction of introduced @PROTEIN$.	1
798	The @COMPOUND$ produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced @PROTEIN$.	1
799	To investigate the activation pathways triggered by @PROTEIN$, ESR spin-trapping techniques using N-tert-butyl-alpha-phenylnitrone (PBN) as spin trap followed by @COMPOUND$ extraction were employed to identify and quantify the free radical intermediates.	0
800	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
801	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
802	None of the compounds altered @PROTEIN$ gene expression, indicating that 3-@COMPOUND$ inhibits CYP11B1 activity on the protein level.	0
803	None of the compounds altered Cyp11b1 gene expression, indicating that 3-@COMPOUND$ inhibits @PROTEIN$ activity on the protein level.	1
804	The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
805	The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
806	The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0
807	@COMPOUND$, a homocamptothecin, targets @PROTEIN$.	1
808	Both MudPIT and cDNA microarray analyses indicate that @COMPOUND$ treatment caused elevated levels of @PROTEIN$.	1
809	Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
810	Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
811	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
812	L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
813	L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
814	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
815	L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0
816	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1
817	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
818	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
819	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
820	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
821	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
822	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
823	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
824	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
825	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
826	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
827	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
828	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
829	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
830	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
831	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
832	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
833	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
834	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
835	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
836	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
837	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, @PROTEIN$ and GPx activities, were determined.	1
838	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and @PROTEIN$, CAT and GPx activities, were determined.	0
839	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
840	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
841	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
842	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
843	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
844	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
845	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
846	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
847	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
848	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
849	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
850	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
851	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
852	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
853	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
854	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
855	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
856	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
857	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
858	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
859	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
860	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
861	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
862	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
863	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
864	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
865	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
866	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and @PROTEIN$ and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
867	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates @PROTEIN$-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
868	@COMPOUND$ causes G(2)/M arrest associated with the modulation of @PROTEIN$ (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
869	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (@PROTEIN$) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
870	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
871	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
872	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
873	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
874	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
875	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
876	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1
877	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1
878	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1
879	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1
880	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0
881	In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1
882	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
883	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
884	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
885	In conclusion, @COMPOUND$ overload in rats induced hypertriglyceridemia and @PROTEIN$ resistance associated with an enhanced oxidative stress.	1
886	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated hemoglobin (HbA1c) and serum @PROTEIN$ were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
887	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated @PROTEIN$ (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
888	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
889	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
890	@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
891	Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
892	Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0
893	Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1
894	Prior to the first dose of @COMPOUND$, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and @PROTEIN$ level with DAS.	0
895	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
896	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, @PROTEIN$ on Tregs, and IL-10 production after burns.	1
897	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and @PROTEIN$ production after burns.	1
898	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of @PROTEIN$, Foxp3 on Tregs, and IL-10 production after burns.	1
899	@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1
900	@PROTEIN$ was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the @COMPOUND$/PKA pathway.	1
901	Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1
902	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and @PROTEIN$, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
903	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum @PROTEIN$ levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
904	Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1
905	@COMPOUND$ exposures that caused a loss of binding function were examined for effects on expression of key NK cell-@PROTEIN$ needed for binding to targets.	0
906	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
907	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
908	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
909	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
910	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
911	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
912	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
913	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
914	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
915	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
916	Western blotting showed that @COMPOUND$ down-regulated @PROTEIN$ protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	1
917	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein @PROTEIN$ (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
918	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific @PROTEIN$ (alphaP2)).	0
919	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (@PROTEIN$), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
920	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor @PROTEIN$, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
921	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins @PROTEIN$ and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.	1
922	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic @PROTEIN$.	1
923	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
924	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
925	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
926	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
927	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
928	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
929	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	1
930	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
931	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
932	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
933	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
934	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
935	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
936	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
937	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
938	Inhibition of mitogen-activated protein kinase (MAPK) and @PROTEIN$ prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
939	Inhibition of mitogen-activated protein kinase (@PROTEIN$) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
940	Inhibition of @PROTEIN$ (MAPK) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
941	@COMPOUND$ up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic @PROTEIN$.	1
942	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent 5-aza-2'-deoxycytidine (alone or in combination with the histone deacetylase inhibitor @COMPOUND$) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
943	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent @COMPOUND$ (alone or in combination with the histone deacetylase inhibitor depsipeptide) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
944	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0
945	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0
946	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
947	In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1
948	@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1
949	@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1
950	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0
951	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
952	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
953	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
954	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
955	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
956	With covalent method, @COMPOUND$ was introduced to immobilize @PROTEIN$.	1
957	Activities of antioxidant enzymes (@PROTEIN$, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
958	Activities of antioxidant enzymes (superoxide dismutase, catalase, @PROTEIN$, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
959	Activities of antioxidant enzymes (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
960	Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
961	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
962	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0
963	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
964	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate cyclase, and @PROTEIN$/2.	1
965	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate @PROTEIN$, and ERK1/2.	1
966	Additionally, UO126 and @COMPOUND$ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1
967	Additionally, UO126 and ODQ inhibited the migration restoring effects of @COMPOUND$ in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1
968	Additionally, UO126 and ODQ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of @COMPOUND$ and @PROTEIN$ pathways in NO-mediated migration.	0
969	GSPs inhibited @COMPOUND$ and 8-Br-cGMP-induced activation of @PROTEIN$/2 in A549 cells.	1
970	GSPs inhibited L-arginine and @COMPOUND$-induced activation of @PROTEIN$/2 in A549 cells.	1
971	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
972	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
973	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
974	Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0
975	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
976	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
977	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
978	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
979	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
980	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
981	The combined treatment strategy not only decreased @PROTEIN$-positive aggregation in striatum, alleviated @COMPOUND$ aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.	0
982	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
983	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
984	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
985	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
986	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
987	The @PROTEIN$ amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of @COMPOUND$ with a little increase in the amount of vanillin production.	1
988	The real synergistic effect of @PROTEIN$ amplification and icdA deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1
989	The real synergistic effect of gltA amplification and @PROTEIN$ deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1
990	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
991	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
992	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, @PROTEIN$ and osteocalcin, in a dose-dependent manner in human dermal fibroblasts.	1
993	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, alkaline phosphatase and @PROTEIN$, in a dose-dependent manner in human dermal fibroblasts.	1
994	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and @COMPOUND$ responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
995	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and @COMPOUND$ in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
996	In Study 1, basal @COMPOUND$ levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma @PROTEIN$ and cortisol (q10 min sampling).	0
997	Basal @PROTEIN$ 0.05), while basal and stimulated plasma @COMPOUND$ levels were higher in patients.	0
998	In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1
999	In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0
1000	Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0
1001	Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0
1002	Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1
1003	@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1
1004	Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1
1005	In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1
1006	In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1
1007	It represents transition in @COMPOUND$-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of @PROTEIN$ activity for anoxia achievement.	1
1008	We examined whether @COMPOUND$ produced locally in the brain may contribute to the activation of @PROTEIN$ in the CNS.	1
1009	Rat dicarboxylate transporter (@PROTEIN$), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary @COMPOUND$ level by reabsorbing citrate from the lumen.	1
1010	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1011	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1012	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1013	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1014	Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1015	Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0
1016	Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1017	@COMPOUND$ and @PROTEIN$ up-regulated cyclinD1 (CD1) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	0
1018	@COMPOUND$ and EGF up-regulated cyclinD1 (@PROTEIN$) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	1
1019	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1020	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1021	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1022	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1023	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1024	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1025	Accumulation of @COMPOUND$ in PA was increased by @PROTEIN$ at 10nM and by IGF-I at 1 nM and 10nM.	1
1026	Accumulation of @COMPOUND$ in PA was increased by insulin at 10nM and by @PROTEIN$ at 1 nM and 10nM.	1
1027	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the @PROTEIN$ levels in @COMPOUND$-induced diabetic rats.	0
1028	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood @COMPOUND$ levels and restoring the @PROTEIN$ levels in streptozotocin-induced diabetic rats.	0
1029	Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0
1030	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1031	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1032	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
1033	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
1034	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
1035	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1036	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1037	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
1038	During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1
1039	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1
1040	Thus, the action of erbstatin on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the @COMPOUND$ status of @PROTEIN$ channels.	1
1041	Thus, the action of @COMPOUND$ on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the cAMP status of @PROTEIN$ channels.	1
1042	In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0
1043	In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0
1044	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1045	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1046	In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1
1047	Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1
1048	For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1049	For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1050	For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0
1051	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1052	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1053	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1054	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1055	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1056	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1057	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1058	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1059	While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1
1060	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
1061	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
1062	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1063	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1064	@COMPOUND$ inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated @PROTEIN$ activation in vascular endothelial cells.	1
1065	Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (@COMPOUND$) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	0
1066	@COMPOUND$ is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (cAMP) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	1
1067	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated protein kinase (@PROTEIN$) in vascular endothelial cells.	1
1068	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated @PROTEIN$ (AMPK) in vascular endothelial cells.	1
1069	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1070	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1071	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1072	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
1073	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1
1074	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1
1075	Osteopontin (@PROTEIN$) inhibits the growth of @COMPOUND$ (COM) and other crystal phases in a phosphorylation-dependent manner.	1
1076	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
1077	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
1078	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
1079	These results confirm the therapeutic potential of @PROTEIN$ blockade on motor symptoms induced by reduced striatal @COMPOUND$ function.	1
1080	Further, they demonstrate that @PROTEIN$ blockade may also have beneficial effects on cognitive deficits induced by @COMPOUND$ depletion.	1
1081	Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired @PROTEIN$-, but not G-protein signaling, was responsible for the observed defect.	0
1082	@PROTEIN$ (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.	0
1083	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
1084	Use of @PROTEIN$ and fibronectin to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1085	Use of tissue transglutaminase and @PROTEIN$ to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1086	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme @PROTEIN$ (tTgase) in conjunction with fibronectin.	1
1087	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with @PROTEIN$.	1
1088	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1089	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
1090	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
1091	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
1092	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1093	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1094	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0
1095	Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1
1096	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as @PROTEIN$ and Fas ligand to suppress cell survival.	1
1097	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as Bax and @PROTEIN$ to suppress cell survival.	1
1098	The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (@PROTEIN$) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1099	The NSCs and neuroblasts had @PROTEIN$ (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1100	The NSCs and neuroblasts had epidermal growth factor receptor (@PROTEIN$) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1101	Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0
1102	Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0
1103	@COMPOUND$ decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	1
1104	FSO decreased fasting @COMPOUND$ by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	0
1105	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (@COMPOUND$) proposed as a likely health-promoting component.	0
1106	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with @COMPOUND$ (EGCG) proposed as a likely health-promoting component.	0
1107	Animal evidence indicates that @COMPOUND$ may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.	0
1108	The purpose of this study was to investigate the effect of dietary supplementation with @COMPOUND$ on @PROTEIN$ resistance and associated metabolic risk factors in man.	1
1109	@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1110	EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1111	In conclusion, regular intake of @COMPOUND$ had no effect on @PROTEIN$ resistance but did result in a modest reduction in diastolic blood pressure.	0
1112	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
1113	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
1114	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
1115	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
1116	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
1117	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
1118	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
1119	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
1120	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
1121	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
1122	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1123	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1124	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1125	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1126	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1127	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1128	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0
1129	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0
1130	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1131	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1132	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1133	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1134	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1135	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1136	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1137	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1138	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1139	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1140	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1141	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1
1142	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1
1143	@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1144	@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1145	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
1146	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1147	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1148	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1149	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
1150	Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1
1151	Inhibition of apoptotic signaling and neointimal hyperplasia by @COMPOUND$ and @PROTEIN$ following vascular injury.	1
1152	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
1153	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1154	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1155	The interaction of quercetin, which is a @COMPOUND$, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1156	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1157	The interaction of quercetin, which is a @COMPOUND$, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1158	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1159	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0
1160	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1
1161	Here, we proposed that @PROTEIN$, a vacuolar amino peptidase, is involved in glutathione catabolism under @COMPOUND$ stress.	1
1162	Thus, under cadmium stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient @COMPOUND$ turnover stored in the vacuole.	1
1163	Thus, under @COMPOUND$ stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.	1
1164	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1165	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1166	We conclude that mitochondrial dysfunction can induce @PROTEIN$ oligomerization via @COMPOUND$ depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.	1
1167	Decreased expression of @PROTEIN$, the binding site for @COMPOUND$, during epileptogenesis and chronic epilepsy.	1
1168	We previously showed that gene expression of @PROTEIN$ (SV2A), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
1169	We previously showed that gene expression of synaptic vesicle protein 2A (@PROTEIN$), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
1170	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of @PROTEIN$ phosphorylation and reactive @COMPOUND$ species generation.	0
1171	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(ADP-ribose) polymerase (@PROTEIN$) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
1172	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(@PROTEIN$-ribose) polymerase (PARP) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
1173	Silencing and attenuating of @PROTEIN$ activation with RNA interference and @COMPOUND$ treatment, respectively, partially suppressed SeC-induced cell apoptosis.	1
1174	Activation of c-@PROTEIN$ N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by @COMPOUND$.	1
1175	Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1176	Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0
1177	Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1178	Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0
1179	Induction in the activity of @PROTEIN$ and azoreductase was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
1180	Induction in the activity of lignin peroxidase and @PROTEIN$ was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
1181	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1182	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1183	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1184	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1185	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1186	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1187	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1188	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1189	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1190	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1191	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1192	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1193	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1194	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1195	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0
1196	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1197	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1198	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1199	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1200	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1201	Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
1202	@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
1203	In this study, a representative FRET system (@PROTEIN$ donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1204	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (@PROTEIN$ (2)) acceptor and @COMPOUND$ substrate).	0
1205	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla @PROTEIN$ donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1206	In this study, a representative FRET system (CFP donor and @PROTEIN$ acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1207	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, @PROTEIN$ (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1208	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1
1209	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1
1210	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
1211	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
1212	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1213	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1214	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1215	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1216	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1217	Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1
1218	We present evidence that ATP generated by synaptic vesicle-associated @PROTEIN$ is harnessed to transport @COMPOUND$ into synaptic vesicles.	1
1219	We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
1220	We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
1221	In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1
1222	A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1
1223	However, @COMPOUND$ was equally effective in @PROTEIN$alpha1(-/-) and wild-type animals, suggesting additional AMPK-independent action of phenformin.	0
1224	The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1225	The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1226	The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1227	The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1228	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1229	The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1230	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1231	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1232	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
1233	Associated with the mitochondrial permeabilization, PdC also induced the release of @PROTEIN$, which is sensitive to inhibition by @COMPOUND$.	1
1234	Toll-like receptor 4 (@PROTEIN$-4)/myeloid differentiation protein-2 complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1235	Toll-like receptor 4 (TLR-4)/myeloid differentiation @PROTEIN$ complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1236	Immunohistochemistry was performed on paraffin-embedded sections, using anti-@COMPOUND$ (5mc) and anti-Acetyl-@PROTEIN$ (Lys 9).	0
1237	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
1238	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
1239	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
1240	@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1
1241	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1242	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1243	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1244	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1245	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1246	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1247	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1248	In @PROTEIN$-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1249	In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (@PROTEIN$), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1250	In CD36-D patients, plasma triglycerides, @PROTEIN$ (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1251	@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1
1252	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0
1253	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0
1254	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
1255	Effects of @COMPOUND$ ethyl ester on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1256	Effects of eicosapentaenoic acid @COMPOUND$ on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1257	Effects of eicosapentaenoic acid ethyl ester on @PROTEIN$ and @COMPOUND$ in lean and overweight (cafeteria diet-fed) rats.	0
1258	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0
1259	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0
1260	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1261	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1262	These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1
1263	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
1264	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
1265	The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1266	The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1267	The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1268	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1269	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1270	Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1271	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1272	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1273	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1274	A novel @COMPOUND$-specific @PROTEIN$ from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	1
1275	A novel @PROTEIN$ (PCL) with specificity towards @COMPOUND$ was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	1
1276	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
1277	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
1278	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
1279	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
1280	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
1281	The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0
1282	The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0
1283	Immobilization of @PROTEIN$ on the @COMPOUND$ modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	1
1284	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1
1285	At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1
1286	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum @COMPOUND$ and urine @PROTEIN$, and a temporary reduction of the creatinine clearance.	0
1287	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1
1288	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1
1289	In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0
1290	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
1291	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
1292	Seasonal variation of the metal (Zn, Fe, @COMPOUND$) and @PROTEIN$ concentrations in the liver cytosol of the European chub (Squalius cephalus L.).	0
1293	The specimens caught in the spring period had higher biometric (liver mass, condition and hepatosomatic indices) and some biochemical parameters (@PROTEIN$ (MT) and @COMPOUND$) that are characteristic for the reproductive period.	0
1294	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1295	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1296	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1297	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1298	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
1299	@COMPOUND$ (CVF) is a structural and functional analog of @PROTEIN$ isolated from cobra venom.	1
1300	Activities of malate- and succinate-dehydrogenases (MDH, @PROTEIN$) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1301	Activities of malate- and succinate-dehydrogenases (@PROTEIN$, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1302	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1303	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1304	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1305	In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1
1306	The @PROTEIN$ were isolated by @COMPOUND$ treatment of crude extracts followed by chromatography on chitin.	1
1307	The 5-HT2AR response dominated the @PROTEIN$ signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist @COMPOUND$ could not be rescued by the 5-HT1AR agonist.	1
1308	Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1
1309	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1310	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1311	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1312	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1313	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
1314	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (@COMPOUND$) of Ascaris suum fused with cholera @PROTEIN$ subunit.	0
1315	Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0
1316	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type @PROTEIN$ (Cu,Zn-superoxide dismutase) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1317	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-@PROTEIN$) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1318	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by @PROTEIN$ active-site @COMPOUND$.	1
1319	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1
1320	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1321	Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1322	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0
1323	Imidazoline-induced amplification of glucose- and @COMPOUND$-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1324	Imidazoline-induced amplification of @COMPOUND$- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1325	@COMPOUND$-induced amplification of glucose- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1326	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
1327	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
1328	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1
1329	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1
1330	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of @PROTEIN$-@COMPOUND$ to activate mTORC1.	1
1331	@COMPOUND$, hematocrit, blood urea nitrogen, total protein, albumin, @PROTEIN$ 0.05) after transport regardless of space allowance.	0
1332	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0
1333	Behavior of rat periodontal ligament cells on @PROTEIN$-immobilized @COMPOUND$ surfaces treated by plasma modification.	1
1334	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1
1335	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1
1336	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1
1337	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1
1338	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1
1339	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1
1340	These were treated with @COMPOUND$ plasma and dipped in @PROTEIN$ solution.	0
1341	Cells from fourth subculture were seeded onto the @PROTEIN$-immobilized @COMPOUND$ surface.	1
1342	These findings suggest that @COMPOUND$ plasma modification can immobilize @PROTEIN$ onto a titanium surface.	1
1343	These findings suggest that oxygen plasma modification can immobilize @PROTEIN$ onto a @COMPOUND$ surface.	1
1344	Effect of short-time exposures to @COMPOUND$ and lead on brain @PROTEIN$ from Danio rerio and Poecilia reticulata.	1
1345	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1
1346	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1
1347	Methylene@COMPOUND$ dehydrogenase) @PROTEIN$) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1348	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (@PROTEIN$) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1349	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) @PROTEIN$ (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1350	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1351	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1352	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
1353	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1354	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1355	Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1
1356	Mechanistically, we showed EphA2 knockdown suppressed @PROTEIN$-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.	1
1357	Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of @PROTEIN$ transcriptional upregulation.	1
1358	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1359	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1360	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
1361	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1362	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1363	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
1364	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
1365	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1366	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1367	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
1368	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and intimin (55.5%) genes were identified by @PROTEIN$.	0
1369	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and @PROTEIN$ (55.5%) genes were identified by PCR.	0
1370	@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1371	K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1372	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1
1373	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0
1374	It appears that GSTM1 null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these @PROTEIN$ (mostly alkylating agents and @COMPOUND$).	1
1375	It appears that GSTM1 null and @PROTEIN$ null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
1376	It appears that @PROTEIN$ null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
1377	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1378	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1379	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1380	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1381	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1382	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1383	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1384	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1385	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1386	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1387	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1388	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1389	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
1390	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
1391	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
1392	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
1393	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
1394	Effects of conjugated linoleic acid plus n-3 @COMPOUND$ on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1395	Effects of @COMPOUND$ plus n-3 polyunsaturated fatty acids on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1396	The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1
1397	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
1398	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
1399	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
1400	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1401	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1402	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1403	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1404	0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0
1405	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or @COMPOUND$ (NO) production.	0
1406	@PROTEIN$-diminished @COMPOUND$ and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.	1
1407	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished @COMPOUND$) or nitric oxide (NO) production.	0
1408	Memory impairment in young women at increased risk of depression: influence of @COMPOUND$ and 5-@PROTEIN$ genotype.	0
1409	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to @COMPOUND$ secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-@PROTEIN$).	0
1410	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, @PROTEIN$ and retinol-binding protein 4 in type 2 diabetic patients.	1
1411	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, IL-6 and retinol-binding @PROTEIN$ in type 2 diabetic patients.	1
1412	The present study explored the effects of flaxseed-derived @COMPOUND$ on inflammatory factors and @PROTEIN$ concentrations in type 2 diabetics, who have higher levels of these biomarkers.	1
1413	No between-treatment differences were found with regard to IL-6 or @PROTEIN$ ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0
1414	No between-treatment differences were found with regard to @PROTEIN$ or RBP4 ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0
1415	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
1416	Here we report the discovery of a series of novel adamantyl @COMPOUND$ as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the @PROTEIN$ gene.	1
1417	To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of @COMPOUND$ were evaluated on recombinant @PROTEIN$ expressed in HEK293T cells.	1
1418	Drosophila responds to detection of diamonopimelic-type microbial @COMPOUND$ through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory @PROTEIN$ pathway.	1
1419	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1
1420	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1
1421	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1
1422	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0
1423	Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1
1424	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1425	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1426	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1427	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1428	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1429	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1430	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1431	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1432	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1433	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1434	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1435	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1436	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1437	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1438	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1439	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1440	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
1441	We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate @PROTEIN$ from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free @COMPOUND$+) concentration.	0
1442	Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient @COMPOUND$+)-sensitive regulator of guanylate @PROTEIN$ activity in cone vision.	0
1443	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the @COMPOUND$ with GSH.	0
1444	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the platinum complex with @COMPOUND$.	0
1445	However, in addition to @PROTEIN$ activity, we discovered that EGST also possesses @COMPOUND$ : disulfide oxidoreductase activity, for which the residue Cys (10) plays an essential role.	0
1446	However, in addition to GST activity, we discovered that EGST also possesses @COMPOUND$ : @PROTEIN$ activity, for which the residue Cys (10) plays an essential role.	0
1447	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
1448	The addition of a bisecting @COMPOUND$ residue by beta(1,4)-@PROTEIN$ (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.	1
1449	Both CTSs targeted enhanced @PROTEIN$ (eYFP) to a @COMPOUND$-sensitive compartment, indicative of Golgi localization.	0
1450	Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1
1451	@PROTEIN$ dehydrogenase activity was observed in H4IIE cells only at subphysiological @COMPOUND$ levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	1
1452	In the present study, we investigated whether CD147/basigin is involved, via its association with @PROTEIN$ and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
1453	In the present study, we investigated whether CD147/@PROTEIN$ is involved, via its association with MCT1 and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
1454	TCblR belongs to the @PROTEIN$ family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like @COMPOUND$-rich region.	1
1455	TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor @PROTEIN$ domains separated by a complement-like @COMPOUND$-rich region.	1
1456	Extended-release PEG-@COMPOUND$ allows for long-term imaging of firefly @PROTEIN$ activity in vivo.	1
1457	Electrospun polyglyconate (@COMPOUND$) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
1458	Electrospun @COMPOUND$ (Maxon) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
1459	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
1460	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
1461	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
1462	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1463	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1464	The low content of sphingomyelin, sulfatide and @COMPOUND$ is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the @PROTEIN$ causes neuronal impairment and myelin deficit.	0
1465	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
1466	Effect of enzyme supplementation at moderate @PROTEIN$ loadings on initial @COMPOUND$ and xylose release from corn stover solids pretreated by leading technologies.	0
1467	For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1468	For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1469	For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1470	For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1471	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
1472	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
1473	Role of @PROTEIN$ and Nox2 in hyperoxia-induced reactive @COMPOUND$ species generation and migration of human lung endothelial cells.	1
1474	Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0
1475	Using newly designed degenerate primers targeting the @PROTEIN$ gene we analysed the potential for @COMPOUND$ utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	1
1476	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
1477	Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1478	Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1479	@PROTEIN$ blockade normalizes hippocampal alterations and cognitive impairment in @COMPOUND$-induced type 1 diabetes mice.	1
1480	Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0
1481	Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1
1482	@PROTEIN$ is also important in the regulation of @COMPOUND$ signaling, a second messenger implicated in learning, memory, and mood.	1
1483	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
1484	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
1485	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
1486	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
1487	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
1488	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
1489	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
1490	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
1491	We therefore hypothesized that a diffusible product of the @PROTEIN$ enzyme reaction (possibly DAG (@COMPOUND$)) mediated the biological effects of the protein.	1
1492	The proliferation of the parental cell line was most efficiently stimulated by @COMPOUND$ (DHT), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1493	The proliferation of the parental cell line was most efficiently stimulated by 5alpha-dihydrotestosterone (@COMPOUND$), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1494	Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0
1495	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1496	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1497	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
1498	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
1499	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
1500	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
1501	@COMPOUND$ efflux to @PROTEIN$, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	0
1502	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), @PROTEIN$ (P = 0.004), apoA-II 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
1503	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), apoA-I (P = 0.004), @PROTEIN$ 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
1504	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
1505	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
1506	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1
1507	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1508	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1509	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0
1510	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0
1511	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0
1512	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of @PROTEIN$/HDAC3.	0
1513	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of HDAC1/@PROTEIN$.	0
1514	This process is associated with an increase in intracellular levels of @COMPOUND$, increase in the acetylation status of @PROTEIN$, and enhanced cell death.	0
1515	Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0
1516	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
1517	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0
1518	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1
1519	We report that the PP inhibition of proteolysis in young rats was mediated by the increased @PROTEIN$ secretion and resulted from a down-regulation of both lysosomal and @COMPOUND$+)-dependent proteolysis.	0
1520	This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0
1521	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
1522	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
1523	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
1524	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
1525	Chemopreventive potential of @COMPOUND$ in mouse skin tumors through regulation of mitochondrial and @PROTEIN$/AKT signaling pathways.	1
1526	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of @PROTEIN$ and IL-13 in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1
1527	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of IL-5 and @PROTEIN$ in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1
1528	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1529	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1530	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the @COMPOUND$-induced attenuation of serum IL-12 and @PROTEIN$.	0
1531	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1
1532	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually TNF-alpha suppression and @PROTEIN$ induction.	0
1533	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually @PROTEIN$ suppression and IL-10 induction.	0
1534	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
1535	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0
1536	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
1537	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
1538	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
1539	Functional analysis of rat liver @PROTEIN$ promoter: differential responsiveness to @COMPOUND$.	1
1540	Wet-wrap treatment using dilutions of @COMPOUND$ ointment and fluticasone propionate cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
1541	Wet-wrap treatment using dilutions of tacrolimus ointment and @COMPOUND$ cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
1542	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
1543	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
1544	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
1545	In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0
1546	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1
1547	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0
1548	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0
1549	Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1
1550	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of @COMPOUND$ and inducible @PROTEIN$ in the liver.	0
1551	Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0
1552	Cell fractionation by @COMPOUND$ gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, @PROTEIN$ localized in fractions corresponding to caveolae.	0
1553	@COMPOUND$ modulation of alpha-, @PROTEIN$, and the norepinephrine transporter in an animal model of depression.	1
1554	@COMPOUND$ modulation of alpha-, gamma-synuclein, and the @PROTEIN$ in an animal model of depression.	1
1555	The @PROTEIN$-selective antidepressant @COMPOUND$ (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	1
1556	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0
1557	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0
1558	In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0
1559	In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0
1560	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (@PROTEIN$), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
1561	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both @PROTEIN$ and inducible nitric oxide synthase (iNOS) in murine Mphi.	1
1562	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of @PROTEIN$ (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
1563	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible @PROTEIN$ (iNOS) in murine Mphi.	1
1564	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (@PROTEIN$) in murine Mphi.	1
1565	A significant increase in @PROTEIN$ activity was observed upon a short pre-incubation (1 hr) with IFN-gamma and subsequent @COMPOUND$ stimulation.	1
1566	A significant increase in arginase activity was observed upon a short pre-incubation (1 hr) with @PROTEIN$ and subsequent @COMPOUND$ stimulation.	0
1567	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated arginase activity is dependent on @PROTEIN$ priming.	1
1568	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated @PROTEIN$ activity is dependent on IFN-gamma priming.	1
1569	This report reveals a singular effect of the combination of @COMPOUND$ and @PROTEIN$, one of the mayor cytokines produced in response to CpG administration in vivo.	1
1570	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
1571	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
1572	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1573	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1574	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1575	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1576	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0
1577	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1
1578	@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1
1579	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
1580	Based on these results we analyzed the expression of either M1 receptors or @PROTEIN$ following @COMPOUND$ treatment of retinal cell cultures.	0
1581	Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0
1582	The results obtained from the Fluo-3 image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the @COMPOUND$+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	1
1583	The results obtained from the @COMPOUND$ image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the Ca(2+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	0
1584	A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0
1585	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1586	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1587	Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0
1588	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0
1589	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0
1590	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1591	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1592	@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1
1593	@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1594	@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1595	Animal studies show that ecosapentaenoic acid (EPA) and @COMPOUND$ (DHA) are effective for the prevention and treatment of @PROTEIN$ resistance (IR).	1
1596	We also found an inhibitory effect of @COMPOUND$ on the associations between cadherin 5, @PROTEIN$ and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	1
1597	We also found a strong inhibitory effect of @COMPOUND$ on hypoxia-induced endothelial cell formation of cords and @PROTEIN$ expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	1
1598	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
1599	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1600	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1601	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1602	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1603	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1604	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1605	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1606	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1607	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1608	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1609	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1610	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1611	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1612	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1613	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1614	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1615	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
1616	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
1617	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
1618	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
1619	Magnesium (Mg), @PROTEIN$ (IL-8), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1620	Magnesium (Mg), interleukin 8 (@PROTEIN$), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1621	@COMPOUND$ (Mg), @PROTEIN$ (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1622	@COMPOUND$ (Mg), interleukin 8 (@PROTEIN$), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1623	Study of multiple binding constants of @COMPOUND$ with human @PROTEIN$ by capillary electrophoresis-frontal analysis and multivariate regression.	1
1624	In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of @COMPOUND$ (DXM), the interaction between DXM and @PROTEIN$ was studied by capillary electrophoresis-frontal analysis (CE-FA).	1
1625	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (@COMPOUND$ ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1626	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by @COMPOUND$ (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1627	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen @COMPOUND$ and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1628	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
1629	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1630	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1631	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1632	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1633	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1
1634	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
1635	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of @PROTEIN$ and Akt : a downstream modulator of cell growth and survival.	1
1636	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of PDGFR beta and @PROTEIN$ : a downstream modulator of cell growth and survival.	1
1637	The mechanisms may include the recently revealed anti-inflammatory effects of @PROTEIN$ as well as its conventional @COMPOUND$ and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	1
1638	Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, @PROTEIN$ activity in parallel with inhibitory effect on cell apoptosis.	0
1639	Recently, we reported stimulatory effect of ghrelin alone and in combination with @PROTEIN$ (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
1640	Recently, we reported stimulatory effect of @PROTEIN$ alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
1641	In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0
1642	In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1
1643	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
1644	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-@PROTEIN$-@COMPOUND$ system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	1
1645	Effect of polyols on the solubility of bovine serum albumin (@PROTEIN$) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
1646	Effect of polyols on the solubility of bovine @PROTEIN$ (BSA) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
1647	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
1648	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
1649	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1650	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1651	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1652	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1653	To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1
1654	The large and diverse family of @PROTEIN$ monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	1
1655	The large and diverse family of cytochrome P450 monooxygenases (@PROTEIN$) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	0
1656	In 98.4% of all @PROTEIN$ sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the @COMPOUND$ center.	0
1657	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1658	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1659	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1660	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1661	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
1662	From the observed Frster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
1663	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
1664	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
1665	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
1666	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (@PROTEIN$) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
1667	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and @PROTEIN$ (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
1668	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a GOD (@PROTEIN$) amperometric biosensor is employed for the glucose determination.	0
1669	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a @PROTEIN$ (glucose oxidase) amperometric biosensor is employed for the glucose determination.	1
1670	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
1671	Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1672	Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1673	Finally, the results showed that the @PROTEIN$ covalently attached onto @COMPOUND$ exhibited the highest enantioselectivity and operational stability.	1
1674	Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0
1675	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
1676	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
1677	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
1678	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
1679	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, @PROTEIN$ (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
1680	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, corticosteroid binding globulin (@PROTEIN$), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
1681	Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0
1682	The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1683	The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1684	The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1685	The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1686	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as @COMPOUND$ and creatinine levels.	0
1687	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as @COMPOUND$ and creatinine levels.	0
1688	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as urea and @COMPOUND$ levels.	0
1689	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as urea and @COMPOUND$ levels.	0
1690	Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
1691	Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
1692	Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0
1693	Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0
1694	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from @PROTEIN$ followed by elevations in vascular smooth muscle (@COMPOUND$+))(i) levels and O(2)(.	0
1695	The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1
1696	Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1
1697	Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1
1698	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
1699	In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1
1700	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
1701	New treatments for type 2 diabetes mellitus are needed to retain @PROTEIN$-@COMPOUND$ coupling and lower the risk of weight gain and hypoglycaemia.	1
1702	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1703	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
1704	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1705	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
1706	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1707	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1708	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
1709	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1710	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of @PROTEIN$, a known Hsp90 client protein.	1
1711	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of Chk1, a known @PROTEIN$ client protein.	0
1712	In addition, we observed a time- and dose-dependent decrease in @PROTEIN$ kinase level, a negative regulator of mitosis, after @COMPOUND$ treatment in gastrointestinal cancer cells.	1
1713	A small cytoplasmic protein, @PROTEIN$, has been identified in human hepatic tissue, but its role in @COMPOUND$ metabolism is unknown.	0
1714	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
1715	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by @PROTEIN$ (CYP7A1) protects against dyslipidemia and atherosclerosis.	1
1716	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by cholesterol 7alpha-hydroxylase (@PROTEIN$) protects against dyslipidemia and atherosclerosis.	1
1717	Therefore, we queried whether @COMPOUND$ is prosurvival in podocytes through a @PROTEIN$-dependent pathway.	0
1718	Optimization of chitosan succinate and chitosan @COMPOUND$ microspheres for oral delivery of @PROTEIN$ using response surface methodology.	0
1719	The relative pharmacological efficacy for chitosan @COMPOUND$ and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral @PROTEIN$ administration (4.68+/-1.52%).	0
1720	Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1
1721	In the present study, we investigated the cellular and molecular mechanisms of @PROTEIN$ regulation by @COMPOUND$ in VSMCs (vascular SMCs).	1
1722	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1723	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1724	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1725	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1726	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1727	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1728	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, CycA, daclizumab, and @PROTEIN$, daily protein excretion and serum @COMPOUND$ increased.	0
1729	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, @PROTEIN$, daclizumab, and MMF, daily protein excretion and serum @COMPOUND$ increased.	0
1730	Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1
1731	@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1
1732	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
1733	Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81 Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87 Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1
1734	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1735	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1736	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1737	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1738	@PROTEIN$, vascular endothelial growth factor, and @COMPOUND$ increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	0
1739	Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1
1740	In the azoxymethane (@COMPOUND$) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
1741	In the @COMPOUND$ (AOM) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
1742	To evaluate @COMPOUND$ (AVP) and @PROTEIN$ plasma concentrations in patients with vasodilatory shock after cardiac surgery.	0
1743	In this study, we report a novel @PROTEIN$ defect in a Tunisian family, in which @COMPOUND$ 23 is substituted by a Stop codon causing a premature termination of translation.	1
1744	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
1745	@COMPOUND$-regulated activity of @PROTEIN$.	1
1746	The biological roles of the @COMPOUND$-regulated conformational equilibrium of @PROTEIN$ are discussed in terms of the self and non-self discrimination mechanism.	1
1747	The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (@PROTEIN$) gene, involved in @COMPOUND$ synthesis.	1
1748	Reduced responses of alpha-MSH or @PROTEIN$-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1749	Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type @PROTEIN$ system in nonsurvivors.	0
1750	Reduced responses of alpha-MSH or Nac-beta-END IRM to @PROTEIN$ and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1751	Reduced responses of @PROTEIN$ or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1752	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1753	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1754	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1755	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1756	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1757	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1758	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1759	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1760	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1761	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1762	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1763	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1764	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1765	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1766	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1767	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1768	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1769	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1770	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1771	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
1772	The previous amphotericin B, @PROTEIN$, hyperbaric @COMPOUND$ and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
1773	The previous @COMPOUND$, @PROTEIN$, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
1774	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
1775	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
1776	Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0
1777	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
1778	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
1779	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0
1780	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
1781	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1
1782	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
1783	Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1
1784	Liposome-encapsulated @PROTEIN$ (LHs) are comparable to red blood cells (RBCs) in terms of @COMPOUND$ (O(2))-carrying capacity.	1
1785	Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1786	Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1787	Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1788	Models of noncoupled dinuclear @COMPOUND$ centers in @PROTEIN$.	1
1789	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
1790	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1
1791	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1
1792	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
1793	The models are significant because they maintain the existing type 1 (T1) @COMPOUND$, electron transfer site of @PROTEIN$ while including the second designed type 2 (T2) copper center that mimics the T2 catalytic sites in the target enzymes.	1
1794	Intraprotein electron transfer (IET) from @COMPOUND$ (FMN) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1
1795	Intraprotein electron transfer (IET) from flavin mononucleotide (FMN) to @COMPOUND$ is essential in NO synthesis by NO synthase (@PROTEIN$).	1
1796	Intraprotein electron transfer (IET) from flavin mononucleotide (@COMPOUND$) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1
1797	The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
1798	The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
1799	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1800	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1801	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
1802	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
1803	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1804	Hepatic antioxidant status viz, @COMPOUND$ (GSH), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1805	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1806	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1807	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1808	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1809	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1810	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1811	@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0
1812	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1813	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-@PROTEIN$ (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1814	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (@PROTEIN$ 12 h) has not been characterized.	0
1815	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (V@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1816	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0
1817	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0
1818	@COMPOUND$ demonstrates potent inhibition of @PROTEIN$-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	1
1819	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0
1820	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1
1821	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1
1822	An acute increase in @COMPOUND$ tension led to Smad activation within 30 minutes, even in the absence of exogenous @PROTEIN$ treatment.	0
1823	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
1824	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1825	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
1826	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
1827	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
1828	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
1829	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1830	The binding of @COMPOUND$ to human @PROTEIN$ was used as the model system in order to evaluate the performance of automated SPME.	1
1831	@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0
1832	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1833	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1834	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1835	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1836	According to the oxidative stress concept, increased vascular @COMPOUND$ and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1837	According to the oxidative stress concept, increased vascular superoxide and @COMPOUND$ production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1838	mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1839	mitochondrial @PROTEIN$ (ALDH-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1840	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0
1841	Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1842	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1843	It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six @COMPOUND$ residues and a thiol ester-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0
1844	It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six histidine residues and a @COMPOUND$-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0
1845	Examination of @COMPOUND$-induced expression of the small heat shock protein gene, @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
1846	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (@PROTEIN$), HSP30, in Xenopus laevis A6 kidney epithelial cells.	1
1847	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (HSP), @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
1848	Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1
1849	Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1
1850	Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0
1851	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1852	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1853	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1854	Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1855	Most interestingly, a proline substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1856	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1857	Most interestingly, a proline substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1858	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1859	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1860	@PROTEIN$-@COMPOUND$ coated microspheres: role of the inner gel in binding and release of the KRFK peptide.	1
1861	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1862	Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1863	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1864	Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1865	No main effect of group assignment on TSST responses was found for @PROTEIN$, @COMPOUND$ or POMS scores.	0
1866	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1
1867	Together, these results provide compelling evidence that @PROTEIN$ does not have a klotho-independent role in the regulation of systemic phosphate and @COMPOUND$ homeostasis.	0
1868	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
1869	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
1870	@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1
1871	DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1
1872	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (@PROTEIN$) inhibitor @COMPOUND$ or pharmacological inhibition of PKB.	1
1873	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor @COMPOUND$ or pharmacological inhibition of @PROTEIN$.	0
1874	@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1875	Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1876	In the mouse model of demyelination-remyelination induced by oral administration of @COMPOUND$, in situ hybridization showed an upregulation of the @PROTEIN$ gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	1
1877	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and @PROTEIN$) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1878	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (@PROTEIN$), microglia (CD11b), or reactive glia (GFAP).	0
1879	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (@PROTEIN$).	0
1880	Cells positive for @PROTEIN$ mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	1
1881	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (@PROTEIN$), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1882	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (@PROTEIN$, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1883	Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0
1884	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
1885	Keeping @COMPOUND$ out of DNA: physiological role, structure and catalytic mechanism of @PROTEIN$.	1
1886	To prevent @COMPOUND$ incorporation into DNA, representatives of the dUTP nucleotidohydrolase (@PROTEIN$) enzyme family eliminate excess dUTP.	1
1887	The @PROTEIN$ binding pocket is highly specific for @COMPOUND$.	1
1888	@COMPOUND$ chain coordination involves Mg2+ and is analogous to that of @PROTEIN$.	1
1889	In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of @COMPOUND$ relies exclusively on @PROTEIN$ activity.	1
1890	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1891	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1892	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1893	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1894	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1895	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1896	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1897	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1898	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1899	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1900	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1901	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1902	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1903	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1904	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1905	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1906	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1907	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1908	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1909	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1910	It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1
1911	An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1
1912	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
1913	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
1914	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
1915	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
1916	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
1917	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
1918	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
1919	Critical role of @PROTEIN$ in prostacyclin production by human endothelial cells under modification of @COMPOUND$ tone.	0
1920	Critical role of @PROTEIN$ in @COMPOUND$ production by human endothelial cells under modification of hydroperoxide tone.	1
1921	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
1922	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
1923	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
1924	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
1925	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and @COMPOUND$ O-demethylation.	1
1926	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both @COMPOUND$ and dextromethorphan O-demethylation.	1
1927	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
1928	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
1929	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1930	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1931	These Ca2+-independent @PROTEIN$ display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains @COMPOUND$ functions.	0
1932	At the end of treatment, BMI, WHR, HbA1c, fasting @COMPOUND$, @PROTEIN$, HOMA-IR, alanine aminotransferase values decreased in both groups.	0
1933	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, @PROTEIN$ (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1934	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, @PROTEIN$, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1935	The anterior pituitary gland contains five types of cells secreting specific hormones (@PROTEIN$, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1936	By combining endosperm @PROTEIN$/SDH suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
1937	By combining endosperm LKR/@PROTEIN$ suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
1938	Amino acid 1092 (AA1092) in @PROTEIN$ 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central @COMPOUND$ group of capsid binders (i.e.	1
1939	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous insulin injection implicating @PROTEIN$ as the primary cause of the observed hypocortisolism.	1
1940	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous @PROTEIN$ injection implicating CYP17 as the primary cause of the observed hypocortisolism.	1
1941	The essential role of glucagon and @PROTEIN$ and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1
1942	The essential role of @PROTEIN$ and insulin and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1
1943	@PROTEIN$ kinase inhibition by @COMPOUND$ ameliorates diabetes-induced microvascular damage.	1
1944	Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1
1945	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
1946	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1947	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
1948	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1949	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1950	The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0
1951	The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0
1952	In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0
1953	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
1954	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
1955	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
1956	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
1957	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
1958	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
1959	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
1960	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
1961	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
1962	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
1963	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
1964	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
1965	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0
1966	Plasma @COMPOUND$ and @PROTEIN$ in Huntington's disease.	0
1967	We assessed plasma @COMPOUND$ (pHVA) and plasma @PROTEIN$ (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	0
1968	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
1969	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1
1970	In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a @COMPOUND$/@PROTEIN$ system.	1
1971	In order to further analyse the protective mode of action, the @COMPOUND$ anion scavenging activity of two extracts was evaluated in a xanthine/@PROTEIN$ system.	0
1972	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (@COMPOUND$) of @PROTEIN$.	1
1973	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
1974	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
1975	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
1976	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
1977	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
1978	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
1979	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
1980	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
1981	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
1982	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1983	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1984	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0
1985	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0
1986	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0
1987	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
1988	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0
1989	A functional @PROTEIN$ system is essential for @COMPOUND$ antiobesity action.	1
1990	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1
1991	Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1
1992	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1
1993	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1
1994	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
1995	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
1996	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
1997	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
1998	Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1
1999	The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2000	The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2001	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, @COMPOUND$, HbA1C, PTH, Mg and creatinine analysis.	0
2002	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, phosphorus, HbA1C, @PROTEIN$, Mg and @COMPOUND$ analysis.	0
2003	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, @COMPOUND$, HbA1C, @PROTEIN$, Mg and creatinine analysis.	0
2004	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, phosphorus, HbA1C, PTH, Mg and @COMPOUND$ analysis.	0
2005	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
2006	In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0
2007	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0
2008	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0
2009	@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1
2010	@PROTEIN$ and II form a ubiquitous @COMPOUND$-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	1
2011	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, @COMPOUND$, norepinephrine, and in vitro-stimulated @PROTEIN$ production.	0
2012	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, @COMPOUND$, and in vitro-stimulated @PROTEIN$ production.	0
2013	Higher NF-kappaB stress responses were associated with lower @COMPOUND$ stress responses (beta=-.37, p=.05), higher pre-stress @PROTEIN$ production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	0
2014	The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1
2015	Given the significant biological roles of @PROTEIN$ and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the @COMPOUND$-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	0
2016	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
2017	A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1
2018	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
2019	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
2020	Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0
2021	Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0
2022	In this work we show that in FaO rat hepatoma cells inhibition of the @PROTEIN$ (EGFR) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
2023	In this work we show that in FaO rat hepatoma cells inhibition of the epidermal growth factor receptor (@PROTEIN$) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
2024	Diminished levels of L-arginine and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2025	Diminished levels of L-@COMPOUND$ and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2026	Diminished levels of L-arginine and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2027	Diminished levels of L-@COMPOUND$ and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2028	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2029	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2030	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2031	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
2032	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2033	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2034	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
2035	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
2036	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
2037	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2038	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2039	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2040	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2041	Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0
2042	Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
2043	Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
2044	Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0
2045	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
2046	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
2047	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
2048	@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1
2049	@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1
2050	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
2051	Purification of an @PROTEIN$ involved in the conversion of methional to @COMPOUND$ in Oenococcus oeni IOEB 8406.	1
2052	Purification of an @PROTEIN$ involved in the conversion of @COMPOUND$ to methionol in Oenococcus oeni IOEB 8406.	1
2053	An @COMPOUND$ (P)H-dependent @PROTEIN$ involved in the reduction of methional was then purified to homogeneity.	1
2054	An NAD (P)H-dependent @PROTEIN$ involved in the reduction of @COMPOUND$ was then purified to homogeneity.	1
2055	Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing @COMPOUND$ (P)H-dependent @PROTEIN$.	1
2056	The purified @PROTEIN$ does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile @COMPOUND$ during MLF.	0
2057	The function of the purified @PROTEIN$ remains unclear, although the role of the sulfur atom in @COMPOUND$ molecules in the interaction between enzyme and substrate was evidenced.	0
2058	The function of the purified @PROTEIN$ remains unclear, although the role of the @COMPOUND$ in methional molecules in the interaction between enzyme and substrate was evidenced.	0
2059	In the present work we studied the effect of @PROTEIN$ and-3 on neuronal @COMPOUND$ release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	0
2060	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
2061	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ A and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
2062	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of protein kinase A and C, as well as @COMPOUND$+)/@PROTEIN$-dependent protein kinase II.	1
2063	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (@COMPOUND$), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
2064	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), @COMPOUND$ (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
2065	All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of mmpS5-@PROTEIN$ genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0
2066	All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of @PROTEIN$-mmpL5 genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0
2067	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1
2068	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1
2069	We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1
2070	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
2071	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
2072	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
2073	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, @PROTEIN$ (PCNA) and cleaved caspase-3.	0
2074	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, proliferating cell nuclear antigen (@PROTEIN$) and cleaved caspase-3.	0
2075	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2076	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2077	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2078	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2079	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2080	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2081	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2082	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2083	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2084	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2085	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2086	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2087	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
2088	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
2089	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2090	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2091	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating @COMPOUND$ and lipid metabolism and controlling energy homeostasis in @PROTEIN$-sensitive tissues.	0
2092	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
2093	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
2094	In addition, SAH caused large increases in markers of inflammation, including @PROTEIN$ and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with @COMPOUND$ significantly reducing these effects.	1
2095	We conclude that block of @PROTEIN$ by @COMPOUND$ may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	1
2096	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
2097	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
2098	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
2099	Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1
2100	Lipase-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized @PROTEIN$ from Candida antarctica (E.C.	1
2101	@PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.	1
2102	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
2103	Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1
2104	Stimulation of choline @PROTEIN$ by @COMPOUND$, a neural cell adhesion molecule ligand.	1
2105	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-@COMPOUND$ or (3)H-ritonavir in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
2106	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-atazanavir or (3)H-@COMPOUND$ in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
2107	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
2108	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
2109	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (@COMPOUND$).	0
2110	The induction of @PROTEIN$ by @COMPOUND$ was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	1
2111	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase @COMPOUND$ (BAY 41-2272).	0
2112	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (@COMPOUND$) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	0
2113	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or @COMPOUND$+)-dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution.	0
2114	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or Ca(2+)-dependent processes; it was lost after patch excision or after membrane @COMPOUND$ depletion but was restored after cholesterol reconstitution.	0
2115	Modulation of Rac1 activity by @COMPOUND$/@PROTEIN$ regulates pulmonary endothelial barrier function.	0
2116	Modulation of @PROTEIN$ activity by @COMPOUND$/DDAH regulates pulmonary endothelial barrier function.	1
2117	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either @COMPOUND$, perindopril, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
2118	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, @COMPOUND$, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
2119	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, perindopril, or @COMPOUND$ while untreated or apocynin-treated non-transgenic littermates served as controls.	0
2120	Requirement of @PROTEIN$ for antidepressive efficiency of @COMPOUND$ : implication in adult hippocampal neurogenesis.	1
2121	Collectively, these findings suggest that @PROTEIN$ is required for the antidepressive action of @COMPOUND$ via regulating adult hippocampal neurogenesis.	1
2122	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
2123	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of lysyl oxidase and @PROTEIN$ mRNA expression.	1
2124	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of @PROTEIN$ and carbonic anhydrase IX mRNA expression.	1
2125	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and @COMPOUND$ intolerance occur in the setting of @PROTEIN$ resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	1
2126	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of @PROTEIN$ not of PP1.	1
2127	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of @PROTEIN$ not of PP1.	1
2128	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of PP2B not of @PROTEIN$.	0
2129	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of PP2B not of @PROTEIN$.	0
2130	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
2131	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
2132	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
2133	As release of @COMPOUND$ can be a rate-limiting step for @PROTEIN$ activity, NADH binding was evaluated for R166wt and R166H enzymes.	1
2134	It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1
2135	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
2136	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0
2137	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
2138	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0
2139	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0
2140	Inhibition of @PROTEIN$ by @COMPOUND$ in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.	1
2141	To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0
2142	To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
2143	To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
2144	Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1
2145	The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0
2146	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
2147	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
2148	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
2149	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
2150	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2151	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2152	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2153	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2154	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2155	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2156	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2157	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2158	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2159	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2160	The erythrocyte @PROTEIN$ activity was higher in @COMPOUND$ group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.	1
2161	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
2162	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
2163	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
2164	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
2165	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2166	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2167	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
2168	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
2169	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
2170	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
2171	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1
2172	Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, @COMPOUND$ and @PROTEIN$.	0
2173	Sympathetic neurogenic Ca2+ signalling in rat arteries: @COMPOUND$, noradrenaline and @PROTEIN$.	0
2174	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential @COMPOUND$ residues but only when coexpressed with the @PROTEIN$.	0
2175	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2176	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2177	Activation of Bax and @PROTEIN$ was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2178	Activation of @PROTEIN$ and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2179	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
2180	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-@COMPOUND$ lipids of archaebacteria.	0
2181	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein @COMPOUND$ by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.	1
2182	@COMPOUND$ is present in lipid deposits in the primate retina: potential implication in the induction of @PROTEIN$ and CNV formation.	1
2183	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
2184	A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0
2185	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of @COMPOUND$ and @PROTEIN$, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	0
2186	Combination of @PROTEIN$ and @COMPOUND$ further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	0
2187	@PROTEIN$ and @COMPOUND$ combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	0
2188	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0
2189	Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1
2190	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1
2191	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1
2192	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding @PROTEIN$ (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2193	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (@PROTEIN$), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2194	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and @PROTEIN$ (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2195	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (@PROTEIN$), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2196	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (@PROTEIN$) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2197	Furthermore, we study the @PROTEIN$ activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor @COMPOUND$.	0
2198	@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1
2199	Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1
2200	0.05) in the overall @COMPOUND$-mediated @PROTEIN$ response.	1
2201	@COMPOUND$-stimulated @PROTEIN$ levels were not significantly different from controls.	1
2202	The inducible form of @PROTEIN$ (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
2203	The inducible form of nitric oxide synthase (@PROTEIN$) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
2204	Atypical sialylated N-@COMPOUND$ structures are attached to neuronal @PROTEIN$.	1
2205	@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1
2206	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2207	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2208	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2209	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2210	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2211	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2212	@PROTEIN$, an intracellular sensor of bacteria-derived @COMPOUND$ (MDP) has been implicated as a key player in intestinal immune health and disease.	1
2213	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
2214	Interaction of @PROTEIN$ and @COMPOUND$ in endemic dilated cardiomyopathy.	1
2215	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in @PROTEIN$ (GPx-1) gene.	1
2216	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in glutathione peroxidase-1 (@PROTEIN$) gene.	1
2217	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
2218	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1
2219	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
2220	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
2221	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
2222	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
2223	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
2224	@PROTEIN$ is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
2225	Recoverin is an important neuronal calcium sensor (@PROTEIN$) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
2226	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
2227	Reactivity of @COMPOUND$ with the (4Fe-4S) cluster of @PROTEIN$ from Escherichia coli.	1
2228	The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1
2229	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2230	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2231	Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1
2232	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
2233	This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
2234	Deletion of the first @COMPOUND$-rich region of the varicella-zoster virus @PROTEIN$ ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	1
2235	The data provide the first demonstration for the presence of @PROTEIN$ in primary cilia of renal epithelial cells, and a functional @COMPOUND$-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	0
2236	The endothelial (Ca(2+))(@COMPOUND$) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
2237	The endothelial (@COMPOUND$+))(CYT) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
2238	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
